Photo credit: www.cnbc.com
Dario Amodei, CEO of Anthropic, recently shared insights about the company’s newest subscription model on CNBC’s Squawk Box during the World Economic Forum in Davos, Switzerland.
On Wednesday, Anthropic, an AI startup partially financed by Amazon, unveiled its Claude’s Max plan, a subscription option for its chatbot that positions itself against OpenAI’s ChatGPT.
For $100 a month, users will access five times the usage offered by the existing Pro plan, while a $200 monthly fee allows for a staggering twenty times the usage. In comparison, OpenAI’s equivalent, ChatGPT Pro, maintains a similar pricing structure at $200 per month.
Founded by previous executives from OpenAI, Anthropic launched its chatbot Claude in March 2023. Since then, demand for generative AI solutions has surged, with businesses eager to integrate these chatbots into their sales, marketing, and customer service departments.
Claude’s Max subscription tier elevates offerings above the free plan and the $20 monthly usage option, but remains beneath Anthropic’s business and enterprise packages. Subscribers will benefit from “priority access to new models and capabilities,” giving them early opportunities to explore and implement cutting-edge features from Claude, as noted by the company’s representatives.
One of the forthcoming features is Claude’s voice mode, which product lead Scott White indicated would be launched soon.
White also conveyed that the impetus for creating the Max usage tier stemmed from a year of requests, particularly resonating with professionals in fields like coding, finance, media, and marketing, who seek to leverage Claude for practical applications.
The new subscription is tailored for advanced users, providing them with priority access to Anthropic’s technological advancements.
“I’m thrilled for the users who regard Claude as essential—they won’t be hindered by prior limitations and will be able to expand their usage to tackle diverse challenges,” White expressed in an interview.
Recently, Anthropic concluded its latest funding round, achieving a valuation of $61.5 billion. Reports from December indicated that the company had reached an annualized revenue of $1 billion, showing a tenfold increase from the previous year, with a clientele that includes both startups and prominent companies like Zoom, Snowflake, Pfizer, and Novo Nordisk.
Don’t miss these insights from CNBC PRO
Source
www.cnbc.com